FindTrial
Sign In

to assess the quality of life in children with epilepsy

Assessmentof quality of life (QoL) and adverse drug events in pediatric patients taking antiepileptic drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038327
Enrollment
100
Registered
2021-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G409- Epilepsy, unspecified

Interventions

None listed

Sponsors

KANAV MEHTA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children in the age group of = 4 to =14-year-old of either sex Children on antiepileptic drugs for 3 months or more and present to pediatrics department, G.G.S. Medical College & Hospital, Faridkot Those parents/guardians willing to give written informed consent

Exclusion criteria

Exclusion criteria: Children having episodes of seizures after head trauma Metabolic cause of seizures Refusal of consent

Design outcomes

Primary

MeasureTime frame
To check QOL in pediatric patient taking antiepileptic drugsTimepoint: ONE TIME EVALUATION—

Secondary

MeasureTime frame
adverse events of antiepileptic agentsTimepoint: one time evauation—

Countries

India

Contacts

Public ContactDr Raj Kumar

GGSMC

anurajkumar76@gmail.com9646599057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026